469 related articles for article (PubMed ID: 12627516)
1. Trends in prostate cancer mortality among black men and white men in the United States.
Chu KC; Tarone RE; Freeman HP
Cancer; 2003 Mar; 97(6):1507-16. PubMed ID: 12627516
[TBL] [Abstract][Full Text] [Related]
2. Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates.
Hankey BF; Feuer EJ; Clegg LX; Hayes RB; Legler JM; Prorok PC; Ries LA; Merrill RM; Kaplan RS
J Natl Cancer Inst; 1999 Jun; 91(12):1017-24. PubMed ID: 10379964
[TBL] [Abstract][Full Text] [Related]
3. Trends in the Incidence of Fatal Prostate Cancer in the United States by Race.
Kelly SP; Rosenberg PS; Anderson WF; Andreotti G; Younes N; Cleary SD; Cook MB
Eur Urol; 2017 Feb; 71(2):195-201. PubMed ID: 27476048
[TBL] [Abstract][Full Text] [Related]
4. Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations.
Jemal A; Fedewa SA; Ma J; Siegel R; Lin CC; Brawley O; Ward EM
JAMA; 2015 Nov; 314(19):2054-61. PubMed ID: 26575061
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer incidence and mortality rates among white and black men.
Merrill RM; Brawley OW
Epidemiology; 1997 Mar; 8(2):126-31. PubMed ID: 9229202
[TBL] [Abstract][Full Text] [Related]
6. Implications of stage-specific survival rates in assessing recent declines in prostate cancer mortality rates.
Tarone RE; Chu KC; Brawley OW
Epidemiology; 2000 Mar; 11(2):167-70. PubMed ID: 11021614
[TBL] [Abstract][Full Text] [Related]
7. Trends in the stage specific incidence of prostate carcinoma in the Detroit metropolitan area, 1973-1994.
Schwartz KL; Severson RK; Gurney JG; Montie JE
Cancer; 1996 Sep; 78(6):1260-6. PubMed ID: 8826949
[TBL] [Abstract][Full Text] [Related]
8. Ultraviolet index and racial differences in prostate cancer incidence and mortality.
Taksler GB; Cutler DM; Giovannucci E; Smith MR; Keating NL
Cancer; 2013 Sep; 119(17):3195-203. PubMed ID: 23744754
[TBL] [Abstract][Full Text] [Related]
9. Past, Current, and Future Incidence Rates and Burden of Metastatic Prostate Cancer in the United States.
Kelly SP; Anderson WF; Rosenberg PS; Cook MB
Eur Urol Focus; 2018 Jan; 4(1):121-127. PubMed ID: 29162421
[TBL] [Abstract][Full Text] [Related]
10. The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence decline in the United States.
Legler JM; Feuer EJ; Potosky AL; Merrill RM; Kramer BS
Cancer Causes Control; 1998 Oct; 9(5):519-27. PubMed ID: 9934717
[TBL] [Abstract][Full Text] [Related]
11. Abrogation of survival disparity between Black and White individuals after the USPSTF's 2012 prostate-specific antigen-based prostate cancer screening recommendation.
Kim IE; Jang TL; Kim S; Modi PK; Singer EA; Elsamra SE; Kim IY
Cancer; 2020 Dec; 126(23):5114-5123. PubMed ID: 32888321
[TBL] [Abstract][Full Text] [Related]
12. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.
Lediju O; Ikuemonisan J; Salami SS; Adejoro O
J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310
[TBL] [Abstract][Full Text] [Related]
13. Cancer surveillance series: interpreting trends in prostate cancer--part III: Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality.
Etzioni R; Legler JM; Feuer EJ; Merrill RM; Cronin KA; Hankey BF
J Natl Cancer Inst; 1999 Jun; 91(12):1033-9. PubMed ID: 10379966
[TBL] [Abstract][Full Text] [Related]
14. Annual Report to the Nation on the Status of Cancer, part II: Recent changes in prostate cancer trends and disease characteristics.
Negoita S; Feuer EJ; Mariotto A; Cronin KA; Petkov VI; Hussey SK; Benard V; Henley SJ; Anderson RN; Fedewa S; Sherman RL; Kohler BA; Dearmon BJ; Lake AJ; Ma J; Richardson LC; Jemal A; Penberthy L
Cancer; 2018 Jul; 124(13):2801-2814. PubMed ID: 29786851
[TBL] [Abstract][Full Text] [Related]
15. Is prostate cancer stage migration continuing for black men in the PSA era?
Dobbs RW; Greenwald DT; Wadhwa H; Freeman VL; Abern MR
Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):210-215. PubMed ID: 28094251
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer incidence, mortality, and survival trends in the United States: 1981-2001.
Sarma AV; Schottenfeld D
Semin Urol Oncol; 2002 Feb; 20(1):3-9. PubMed ID: 11828352
[TBL] [Abstract][Full Text] [Related]
17. The lifetime risk of developing prostate cancer in white and black men.
Merrill RM; Weed DL; Feuer EJ
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):763-8. PubMed ID: 9332756
[TBL] [Abstract][Full Text] [Related]
18. Racial disparities in prostate cancer incidence rates by census division in the United States, 1999-2008.
Cook MB; Rosenberg PS; McCarty FA; Wu M; King J; Eheman C; Anderson WF
Prostate; 2015 May; 75(7):758-63. PubMed ID: 25619191
[TBL] [Abstract][Full Text] [Related]
19. Racial disparities in late-stage prostate cancer: a SEER analysis 2005-2015.
Rodriguez S; Sparks AD; Zhou H; Amdu RL; Lin J
Can J Urol; 2019 Oct; 26(5):9946-9951. PubMed ID: 31629445
[TBL] [Abstract][Full Text] [Related]
20. Changing Incidence of Metastatic Prostate Cancer by Race and Age, 1988-2015.
Dall'Era MA; deVere-White R; Rodriguez D; Cress R
Eur Urol Focus; 2019 Nov; 5(6):1014-1021. PubMed ID: 29735368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
